For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
SVP, Translational Medicine, Global Head of Biomarkers and Genomic Medicine
Dr. Qu, SVP of Translational Medicine and Global Head of Biomarkers and Genomic Medicine at Parexel, is an innovative scientific and team leader in Genomic Medicine and Clinical Research. At Parexel, she leads global team for therapeutic strategy development and precision medicine implementation, provision of scientific and medical guidance, and consulting on partnerships across broad therapeutic areas with a focus in Oncology and Immuno-oncology. She also serves as a core member of Parexel’s Oncology CoE (Centre of Excellence) and has served on multiple oncology professional committees including AACR and FDA IWG. She has received multiple awards in Oncology space including recent recognition of Women Leadership in Immuno-Oncology in 2021 and 2022.
Dr. Qu has over 20 years of extensive experience working in academic research and industry R&D across drug discovery and clinical development. Prior to joining Parexel, Dr. Qu has served in increasingly senior roles in large pharma including GSK, P&G Pharmaceutical, where she has led many complex multi-omics, disease pathway modeling, biomarker and clinical development projects across broad therapeutic areas including oncology, immuno-inflammation, infectious disease, respiratory, dermatology, musculoskeletal, cardiovascular, and metabolic diseases. Dr. Qu also has extensive clinical development experience via serving as medical director to develop early phase clinical trials, monitor and assess safety, co-author and signoff study reports.
Throughout her career Dr. Qu has been actively engaged in leading and applying scientific innovations to translational medicine. In addition to invited book chapters and global conference speakers, she has authored over 50 publications for her work in translating complex genomics and clinical data in precision medicine and accelerated therapy development.
Dr. Qu earned her M.S. in Biomedical Informatics from Columbia University and Ph.D. in Biomedical Informatics from University of Cincinnati/Cincinnati Children’s Hospital Medical Center. She received her medical degree and completed her internal medicine residency from Shandong Medical University and Chinese Academy of Medical Sciences, followed by postdoctoral training and research faculty tenure in Genomics and Cancer Genetics at Columbia University Medical Center.